Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published: Nov 2022 - Pages: 589
Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) Drugs in Development by Therapy Areas an...
Published: Aug 2022 - Pages: 92
Sickle Cell Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Published: Jul 2022 - Pages: 277
Pulmonary Arterial Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Up...
Published: May 2022 - Pages: 370
Acquired (Autoimmune) Hemolytic Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 210
Pulmonary Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players
Published: May 2022 - Pages: 180
Hypertension (Cardiovascular) - Drugs in Development, 2021
Published: Nov 2021 - Pages: 872
Coagulation Factor XI (Plasma Thromboplastin Antecedent or F11 or EC 3.4.21.27) - Drugs In Development, 2021
Published: Aug 2021 - Pages: 80
Stroke (Cardiovascular) - Drugs In Development, 2021
Published: Aug 2021 - Pages: 862
Congestive Heart Failure (Heart Failure) (Cardiovascular) - Drugs In Development, 2021
Published: Jun 2021 - Pages: 760
Coagulation Factor XII (Hageman Factor or HAF or F12 or EC 3.4.21.38) - Drugs in Development, 2021
Published: Apr 2021 - Pages: 35
Proteinase Activated Receptor 1 (PAR1 or Coagulation Factor II Receptor or Thrombin Receptor or F2R) - Drugs in Developm...
Published: Apr 2021 - Pages: 35
Gap Junction Alpha 1 Protein (Connexin 43 or Gap Junction 43 Kda Heart Protein or GJA1) - Drugs in Development, 2021
Published: Apr 2021 - Pages: 35
Coagulation Factor VII (Proconvertin or Serum Prothrombin Conversion Accelerator or SPCA or Eptacog Alfa or F7 or EC 3.4...
Published: Apr 2021 - Pages: 50
Fibrinogen (Coagulation Factor I or FG) - Drugs in Development, 2021
Published: Apr 2021 - Pages: 40
Prothrombin (Coagulation Factor II or F2 or EC 3.4.21.5) - Drugs in Development, 2021
Published: Apr 2021 - Pages: 50
Sodium Channel Protein Type 5 Subunit Alpha (Sodium Channel Protein Cardiac Muscle Subunit Alpha or Voltage Gated Sodium...
Published: Apr 2021 - Pages: 50
Coagulation Factor X (Stuart Prower Factor or Stuart Factor or F10 or EC 3.4.21.6) - Drugs in Development, 2021
Published: Apr 2021 - Pages: 60
Receptor Tyrosine Protein Kinase ERBB 2 - Drugs in Development, 2021
Published: Apr 2021 - Pages: 220
Coagulation Factor IX (Christmas Factor or Plasma Thromboplastin Component or F9 or EC 3.4.21.22) - Drugs in Development...
Published: Apr 2021 - Pages: 60
